These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


143 related items for PubMed ID: 9868303

  • 1. [Multi-parametric analysis for leukemic immunophenotyping].
    Ujiie M, Sonoda A, Todoroki T, Amano H, Uchida T, Kawai Y, Watanabe K.
    Rinsho Byori; 1998 Nov; 46(11):1163-7. PubMed ID: 9868303
    [Abstract] [Full Text] [Related]

  • 2. [Cytomorphology of acute mixed leukemia].
    Sucić M, Batinić D, Zadro R, Mrsić S, Labar B.
    Acta Med Croatica; 2008 Oct; 62(4):379-85. PubMed ID: 19205415
    [Abstract] [Full Text] [Related]

  • 3. Immunophenotyping of leukemias using a cluster of differentiation antibody microarray.
    Belov L, de la Vega O, dos Remedios CG, Mulligan SP, Christopherson RI.
    Cancer Res; 2001 Jun 01; 61(11):4483-9. PubMed ID: 11389079
    [Abstract] [Full Text] [Related]

  • 4. [Immunophenotyping of acute leukemias: diagnostic and pronostic utility in Abidjan, Côte d'Ivoire].
    Inwoley KA, Sawadogo D, Mizero L, Salou M, Karim N, Sangaré A.
    Bull Soc Pathol Exot; 2004 Jun 01; 97(5):319-22. PubMed ID: 15787262
    [Abstract] [Full Text] [Related]

  • 5. Flow cytometric characterization of acute myeloid leukemia. Part 1. Significance of light scattering properties.
    Terstappen LW, Könemann S, Safford M, Loken MR, Zurlutter K, Büchner T, Hiddemann W, Wörmann B.
    Leukemia; 1991 Apr 01; 5(4):315-21. PubMed ID: 2027298
    [Abstract] [Full Text] [Related]

  • 6. Cytochemical and immunological phenotying of acute nonlymphoblastic leukemia in Thai patients.
    Pokatikorn W, Apibal S, Atichartakarn V, Sriurairatana S, Chiewsilp D, Thitikawin P, Timvipark C.
    J Med Assoc Thai; 1996 Nov 01; 79(11):708-14. PubMed ID: 8997009
    [Abstract] [Full Text] [Related]

  • 7. Role of FAB classification of acute leukemias in era of immunophenotyping.
    Sachdeva MU, Ahluwalia J, Das R, Varma N, Garewal G.
    Indian J Pathol Microbiol; 2006 Oct 01; 49(4):524-7. PubMed ID: 17183842
    [Abstract] [Full Text] [Related]

  • 8. [Immunophenotypic analysis in acute leukemia].
    Akashi K, Harada M.
    Nihon Rinsho; 1992 Jun 01; 50(6):1229-35. PubMed ID: 1518138
    [Abstract] [Full Text] [Related]

  • 9. [Morphological, immunological and cytogenetic diagnosis in acute leukemias].
    Ratei R, Sperling C, Ludwig WD.
    Ther Umsch; 1996 Feb 01; 53(2):88-96. PubMed ID: 8629269
    [Abstract] [Full Text] [Related]

  • 10. Light scatter and immunophenotypic characteristics of blast cells in typical acute promyelocytic leukemia and its variant.
    Piedras J, López-Karpovitch X, Cárdenas R.
    Cytometry; 1998 Aug 01; 32(4):286-90. PubMed ID: 9701397
    [Abstract] [Full Text] [Related]

  • 11. Comparison of mRNA abundance quantified by gene expression profiling and percentage of positive cells using immunophenotyping for diagnostic antigens in acute and chronic leukemias.
    Kern W, Kohlmann A, Schoch C, Schnittger S, Haferlach T.
    Cancer; 2006 Nov 15; 107(10):2401-7. PubMed ID: 17041886
    [Abstract] [Full Text] [Related]

  • 12. Usefulness of anti-CD117 in the flow cytometric analysis of acute leukemia.
    Hans CP, Finn WG, Singleton TP, Schnitzer B, Ross CW.
    Am J Clin Pathol; 2002 Feb 15; 117(2):301-5. PubMed ID: 11863227
    [Abstract] [Full Text] [Related]

  • 13. Haematologic and immunophenotypic profile of acute myeloid leukemia: an experience of Tata Memorial Hospital.
    Ghosh S, Shinde SC, Kumaran GS, Sapre RS, Dhond SR, Badrinath Y, Ansari R, Kumar A, Mahadik S, Chougule AB, Nair CN.
    Indian J Cancer; 2003 Feb 15; 40(2):71-6. PubMed ID: 14716122
    [Abstract] [Full Text] [Related]

  • 14. Myeloid enzymes profile related to the immunophenotypic characteristics of blast cells from patients with acute myeloid leukemia (AML) at diagnosis.
    Klobusicka M, Kusenda J, Babusikova O.
    Neoplasma; 2005 Feb 15; 52(3):211-8. PubMed ID: 15875082
    [Abstract] [Full Text] [Related]

  • 15. Prognostic value of immunophenotyping in elderly patients with acute myeloid leukemia: a single-institution experience.
    Plesa C, Chelghoum Y, Plesa A, Elhamri M, Tigaud I, Michallet M, Dumontet C, Thomas X.
    Cancer; 2008 Feb 01; 112(3):572-80. PubMed ID: 18085638
    [Abstract] [Full Text] [Related]

  • 16. CD79a expression in acute myeloid leukemia t(8;21) and the importance of cytogenetics in the diagnosis of leukemias with immunophenotypic ambiguity.
    Kozlov I, Beason K, Yu C, Hughson M.
    Cancer Genet Cytogenet; 2005 Nov 01; 163(1):62-7. PubMed ID: 16271957
    [Abstract] [Full Text] [Related]

  • 17. Leukemias of indeterminant lineage.
    Lee EJ, Schiffer CA.
    Clin Lab Med; 1990 Dec 01; 10(4):737-54. PubMed ID: 2272172
    [Abstract] [Full Text] [Related]

  • 18. [Detection of minimal residual disease in acute leukemias by flow cytometry].
    Scolnik MP.
    Medicina (B Aires); 2000 Dec 01; 60 Suppl 2():83-6. PubMed ID: 11188938
    [Abstract] [Full Text] [Related]

  • 19. [Monoclonal antibodies in diagnosis of acute leukemias].
    Krawczyńska A, Robak T.
    Przegl Lek; 1996 Dec 01; 53(1):20-5. PubMed ID: 8711170
    [Abstract] [Full Text] [Related]

  • 20. Impact of immunophenotyping on management of acute leukemias.
    Béné MC, Bernier M, Castoldi G, Faure GC, Knapp W, Ludwig WD, Matutes E, Orfao A, van't Veer M.
    Haematologica; 1999 Nov 01; 84(11):1024-34. PubMed ID: 10553164
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.